Stay updated with breaking news from Jun Guo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Junshi Biosciences, Junshi Biosciences Highlights Pipeline Advances in Immuno-Oncology Through Nearly 40 Data Presentations of Icatolimab and Toripalimab at ASCO 2022
Press release content from PR Newswire. The AP news staff was not involved in its creation.
在《新法国哲学（The New French Philosophy）》一书中，伊恩·詹姆斯就曾作出这样的尝试，他将南希论及的主要话题及其立场归纳如下：（1）南希试图以“共在”（co-existence）和独一…
[December 28, 2020] Junshi Biosciences Announces Inclusion of Toripalimab in The China National Reimbursement Drug List SHANGHAI, China, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877; SSE: 688180), an innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, is pleased to announce that toripalimab has been included in the updated National Reimbursement Drug List (NRDL) (2020 Edition) for the treatment of melanoma by the China National Healthcare Security Administration (NHSA). The primary drug format specif...